Patient Preference and Adherence,
Journal Year:
2025,
Volume and Issue:
Volume 19, P. 543 - 567
Published: March 1, 2025
To
describe
24-month
treatment
patterns,
healthcare
resource
utilization
(HCRU),
and
direct
costs
of
patients
initiating
galcanezumab
(GMB)
versus
standard
care
migraine
preventive
medications
(SOC),
stratified
by
gender
type.
This
retrospective
cohort
study
used
Optum's®
de-identified
Market
Clarity
database
(September
2018-March
2020)
included
adults
with
≥1
claim
for
GMB
or
SOC.
Patients
in
the
were
(female/male)
type
(CM/EM),
propensity
score
matched
1:1
to
SOC
cohort.
Treatment
all-cause
migraine-related
HCRU,
cohorts
compared
using
a
Z-test
reported
over
24
months.
Following
stratification
matching,
following
patient
pairs:
2015-female,
292-male,
1024-CM,
1282-EM.
adherence,
measured
proportion
days
covered,
median
time
discontinuation
significantly
greater
those
females,
males,
CM,
EM
(all
p
<0.001).
Over
months,
reduction
ambulatory
visits,
office
medical
higher
females
CM.
Increases
HCRU
associated
medication
counts
total
pharmacy
all
subgroups.
While
months
prevention,
better
adherence
longer
duration
regardless
support
use
European Journal of Neurology,
Journal Year:
2025,
Volume and Issue:
32(3)
Published: March 1, 2025
Migraine
is
a
debilitating
neurological
disease
with
multifaceted
pathophysiology.
Pre-existing
comorbidities
may
influence
the
risk
of
developing
migraine.
This
review
and
meta-analysis
aim
to
present
comprehensive
overview
known
predisposing
individuals
new
migraine
onset,
thereby
improving
our
understanding
respective
diseases'
interactions.
A
systematic
search
PubMed
EMBASE
identified
studies
on
pre-existing
as
factors
for
onset.
We
performed
three-level
meta-analyses
employing
restricted
maximum
likelihood
estimation
calculate
pooled
ratios
(pRR).
Subgroup
sensitivity
analyses
were
conducted
assess
robustness
data.
Risk
bias
(RoB)
was
assessed
Quality
in
Prognostic
Studies
Tool.
pre-registered
Prospero
(CRD42024501140).
From
total
17,330
records,
we
38
studies,
encompassing
124
effect
sizes
from
58
exposures.
Most
(n
=
28,
74%)
had
low
RoB.
Heterogeneity
high
(>90%),
primarily
due
within-study
differences
(>50%),
not
significantly
impacted
by
moderator
tests
or
exclusion
outliers.
found
increased
risks
onset
associated
prior
atopic
conditions
[pRR
1.53
(1.15,
2.03)],
psychiatric
psychological
disorders
2.63
(1.79,
3.85)],
sleep
1.89
(1.26,
2.85)],
cardiovascular
1.72
(1.07,
2.76)].
atopic,
psychiatric,
sleep,
are
likely
shared
genetic
predisposition
mediating
like
stress
inflammation.
Future
research
should
focus
these
associations
advance
targeted
prevention
treatment
strategies.
Expert Opinion on Biological Therapy,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 15
Published: Jan. 20, 2025
Migraine
is
a
disabling
neurological
disorder
with
complex
neurobiology.
It
appears
as
cyclic
of
sensory
processing,
affecting
multiple
systems
beyond
nociception.
Overlapping
mechanisms,
including
dysfunctional
processing
input
from
brain
structures
are
involved
in
the
generation
attacks.
This
review
provides
comprehensive
synthesis
on
migraine
neurobiology,
which
was
additionally
informed
by
search
research
databases
(PubMed,
ClinicalTrials.gov).
Findings
most
recent
literature
integrated
pathophysiological
framework.
By
combining
mechanistic
insights
and
clinical
trial
data,
this
highlights
trajectory
precision
medicine
treatment,
offering
perspective
near
future
targeted
individualized
therapeutic
strategies.
Recent
advances
neurobiology
offer
potential
solutions
to
longstanding
challenges.
While
CGRP
therapies
have
shown
promise
addressing
specific
pathophysiology
suggests
that
combination
targeting
pathways
could
be
beneficial
prevention.
The
growing
diversity
treatment
options
presents
challenges
therapy
selection,
underscoring
need
for
predictive
biomarkers.
These
innovations
can
optimize
strategies
improve
patient
outcomes.
As
field
progresses,
personalized,
multimodal
approaches
poised
become
standard
care,
significantly
advancing
area.
Frontiers in Pain Research,
Journal Year:
2025,
Volume and Issue:
6
Published: Feb. 3, 2025
Background
Recurrent
headaches
in
headache
disorders
adversely
impact
quality
of
life
and
job.
Migraines
tension-type
TTH)
are
the
most
common
primary
a
prominent
cause
disability
globally.
However,
few
research
compare
illness
burden
China,
India,
United
States
(US),
Japan.
Methods
Global
Chinese,
US,
Indian,
Japanese
migraine
TTH
incidence,
prevalence,
disability-adjusted
years
were
taken
from
GBD
database
for
1990–2021.
The
data
is
studied
utilizing
decomposition
analysis,
health
inequality
research,
joinpoint
regression
model,
Bayesian
Average
Annual
Percentage
Change
(BAPC)
model.
Results
study
found
that
mostly
affects
women
aged
15–49,
while
evenly
distributed
across
gender
age.
worldwide
average
annual
percentage
change
(AAPC)
disease-adjusted
(DALYs)
1990
to
2021
was
0.0357,
statistically
significant
trend
(
p
<
0.001),
as
determined
using
analysis.
China
exhibited
quickest
rise
incidence
well
age-standardized
rate
(ASR)
DALYs,
four
nations
analyzed.
US
had
highest
value
these
indicators.
Forecasting
models
reveal
without
policy
action,
prevalence
will
grow
but
would
stay
unchanged.
Decomposition
showed
population
expansion
major
migraines
TTH,
which
be
slightly
alleviated
by
aging.
Health
disparities
economic
growth
areas
lessened
between
2021,
according
report.
Conclusion
Globally
have
increased
since
1990.
becoming
more
young
middle-aged
women,
so
treatment
professionals
should
invest
patient
education
raise
awareness
improve
self-management
reduce
disease
medical
costs.
Neurology and Therapy,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 14, 2025
Migraine
affects
women
three
times
more
often
than
it
does
men,
and
various
mechanisms
may
explain
this
incidence,
including
the
key
role
of
female
sex
hormones.
Fluctuations
in
levels
these
hormones
their
feedback
control
regulate
menstrual
cycle,
pregnancy,
puerperium,
perimenopause,
menopause.
They
can
influence
occurrence
severity
migraine
throughout
reproductive
period.
Of
particular
importance
seems
to
be
perimenopausal
period,
which
is
associated
with
an
increase
migraine,
especially
considered
disabling
less
amenable
treatment
non-menstrual
attacks.
This
article
reviews
available
evidence
documenting
relationship
between
menopause,
diagnostic
considerations
attempt
determine
management
periods
a
woman's
life.
Special
considerations,
future
directions,
unmet
needs
for
menopausal
are
also
discussed.
Clinical and Translational Neuroscience,
Journal Year:
2025,
Volume and Issue:
9(1), P. 3 - 3
Published: Jan. 20, 2025
Introduction:
Cortical
spreading
depression
(CSD)
is
thought
to
be
the
pathophysiologic
correlate
of
migraine
aura.
In
experimental
animals,
CSD
was
shown
cause
an
increase
in
oxyhemoglobin.
Susceptibility
weighted
imaging
(SWI)
on
magnetic
resonance
(MRI)
depicts
cerebral
veins
according
their
concentration
The
aim
this
study
assess
whether
distribution
SWI
changes
people
with
aura
resembles
clinical
presentation,
a
focus
topology.
Methods:
retrospective
single-center
study,
patients
were
included
if
they
(i)
had
acute
focal
neurological
symptoms
beginning
visual
symptoms,
(ii)
underwent
head
MRI
including
within
eight
hours
symptom
onset,
(iii)
showed
dilated
veins,
and
(iv)
discharge
diagnosis
Eleven
predefined
regions
interest
(ROIs)
assessed
for
prominent
(PFVs)
SWI.
We
determined
correlated
topography
ROIs
PFVs.
Results:
found
posterior
anterior
gradient
during
when
present.
Conclusion:
might
able
detect
traces
CSD.
areas
corresponds
anatomically
canonical
succession
Neurology International,
Journal Year:
2025,
Volume and Issue:
17(2), P. 15 - 15
Published: Jan. 21, 2025
Migraine
with
aura
(MwA)
is
a
common
and
severely
disabling
neurological
disorder,
characterised
by
transient
yet
recurrent
visual
disturbances,
including
scintillating
scotomas,
flickering
photopsias,
complex
geometric
patterns.
These
episodic
phenomena
significantly
compromise
daily
functioning,
productivity,
overall
quality
of
life.
Despite
extensive
research,
the
underlying
pathophysiological
mechanisms
remain
only
partially
understood.
Cortical
spreading
depression
(CSD),
propagating
wave
neuronal
glial
depolarisation,
has
been
identified
as
central
process
in
MwA.
This
phenomenon
triggered
ion
channel
dysfunction,
leading
to
elevated
intracellular
calcium
levels
excessive
glutamate
release,
which
contribute
widespread
cortical
hyperexcitability.
Genetic
studies,
particularly
involving
CACNA
gene
family,
further
implicate
dysregulation
channels
pathogenesis
Recent
advances
neuroimaging,
functional
magnetic
resonance
imaging
(fMRI),
have
provided
critical
insights
into
neurophysiology
results
support
role
CSD
basic
mechanism
behind
MwA
imply
that
dysfunction
endures
beyond
brief
episodes,
possibly
due
chronic
or
The
cortex
patients
exhibits
activation
patterns
comparison
other
neuroimaging
supporting
possibility
it
disease-specific
biomarker.
Its
distinctive
sensory
cognitive
characteristics
are
influenced
interplay
cortical,
vascular,
genetic
factors,
demonstrating
multifactorial
nature
We
now
know
much
more
about
pathophysiology
thanks
combination
molecular
research
sophisticated
techniques
like
arterial
spin
labelling
(ASL)
fMRI.
review
aims
synthesize
current
knowledge
analyse
neurophysiological
targets,
providing
foundation
for
developing
targeted
therapies
modulate
excitability,
restore
neural
network
stability,
alleviate
burden
migraine
aura.
most
important
impactful
our
field
focus
this
review,
highlights
developments
their
contributions
treatment
The Journal of Headache and Pain,
Journal Year:
2025,
Volume and Issue:
26(1)
Published: Jan. 31, 2025
Headache
disorders
are
common,
including
in
the
working
population.
Clinicians
caring
for
patients
with
headache
need
to
be
aware
of
work-related
factors
as
potential
causes
or
triggers
disorders,
and
consider
impact
on
fitness-to-work,
especially
safety-sensitive
decision-critical
roles.
Such
fitness-to-work
determination
should
include
individualized
consideration
nature
disorder
itself,
pattern
headache,
sleep
deprivation
it
relates
fitness
do
shiftwork,
medication
substance
side
effects,
implications
associated
medical
psychiatric
conditions,
symptom
feigning
malingering
secondary
gain.
As
clinicians
often
struggle
determinations,
a
structured
approach
assessments
conditions
other
pain
would
improve
clarity
increase
quality
care
provided
patients,
benefits
workplace
safety
policy
this
arena
well.
Alcohol and Alcoholism,
Journal Year:
2025,
Volume and Issue:
60(2)
Published: Jan. 19, 2025
It
seems
that
diet
is
one
of
the
main
triggers
migraine;
most
studied
alcohol,
and
also,
over
years,
red
wine
has
been
shown
to
trigger
headaches.
Therefore,
this
systematic
review
meta-analysis
aims
examine
strength
association
between
consumption
migraine.
In
meta-analysis,
a
search
MEDLINE
(via
PubMed),
Scopus,
Cochrane,
Web
Science
databases
was
conducted
assess
migraine,
covering
baseline
December
2023.
Pooled
Odds
Ratio
(p-OR)
were
calculated
using
DerSimonian
Laird
methods.
This
study
previously
registered
in
PROSPERO
(CRD42024511115).
The
risk
bias
evaluated
Quality
Assessment
Tool
for
Observational
Cohort
Cross-Sectional
Studies.
Five
studies
included
review,
only
four
them
meta-analysis.
Using
method,
p-OR
effect
on
migraine
0.63
(95%
CI
0.36-1.09).
after
assessment
showed
moderate
bias.
findings
indicate
there
no
conclusive
evidence
support
an
increased
or
decreased
associated
with
consumption.
Expert Review of Neurotherapeutics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 11, 2025
Background
The
burden
of
migraine
in
Mexican
Emergency
Department
(ED)
settings
remains
understudied.
This
study
aimed
to
determine
the
frequency
migraine-related
ED
visits
within
Ministry
Health's
(MMoH)
database
and
analyze
their
demographics
treatment
patterns.